2014 October Dermatology Survey
2014 October Dermatology Survey
$599.00
We performed a 5-question survey of 21 dermatologists to gauge usage of drugs and devices for the treatment of common dermatological conditions and for aesthetic procedures.
Publisher: Biomedtracker
- Description
- Samples
Overview
We performed a 5-question survey of 21 dermatologists on treatment practices for acne, rosacea, actinic keratosis, and aesthetic procedures.
Drugs covered include Aczone (AGN), Finacea (Bayer)/Azelex (AGN), Differin (Galderma and generics), Epiduo (Galderma), and oral isotretinoin. Physicians also provided usage information on ablative and non-ablative laser skin resurfacing, photodynamic therapy, and dermal fillers marketed by Allergan (AGN), Valeant (VRX), and Merz.
This survey was performed in conjunction with MedDeviceTracker, a forthcoming product that will provide coverage of the medtech (medical device and diagnostic) marketplace.
Figure: Percent of acne patients receiving the given medication
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Dermatology KOL Interview 
Sign up to the